Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 4/20 | 0.38 |
| ▸ | CTSS | P25774 | 4/20 | 0.38 |
| ▸ | CTSB | P07858 | 4/20 | 0.38 |
| ▸ | CTSK | P43235 | 3/20 | 0.38 |
| ▸ | AAK1 | Q2M2I8 | 14/20 | 0.37 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.34 |
| ▸ | GSK3B | P49841 | 1/20 | 0.34 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.34 |
| ▸ | BMP2K | Q9NSY1 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | NEK2 | P51955 | 1/20 | 0.32 |
| ▸ | PLK1 | P53350 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4701632 | 0.91 | FNTA (0.34) | — | |
| SCHEMBL4701440 | 0.91 | CTSL (0.40) | CTSLCTSSCTSBCTSKMKNK1 | |
| SCHEMBL4703027 | 0.89 | CTSK (0.31) | CTSLCTSSCTSBCTSK | |
| SCHEMBL4701995 | 0.87 | CTSK (0.37) | CTSLCTSSCTSBCTSK | |
| SCHEMBL4705219 | 0.86 | F11 (0.32) | — | |
| SCHEMBL4699905 | 0.84 | CTSS (0.41) | CTSLCTSSCTSBCTSKAAK1 | |
| SCHEMBL4703327 | 0.83 | CTSL (0.46) | CTSLCTSSCTSBCTSK | |
| SCHEMBL4701807 | 0.83 | TGFBR1 (0.36) | CTSLCTSSCTSBCTSK | |
| SCHEMBL4703250 | 0.83 | CTSL (0.46) | CTSLCTSSCTSBCTSK | |
| SCHEMBL4701334 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1372655-B1 | CATHEPSIN CYSTEINE PROTEASE INHIBITORS | MERCK FROSST CANADA LTD (CA) | 2008-10-01 | — | — | EP | disclosed |